Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Total article views   HTML views PDF downloads Totals
6,947 Dovepress* 6,845+ 1,424 8,269
PubMed Central* 102 48 150
Totals 6,947 1,472 8,419
*Since 19 April 2017

View citations on PubMed Central and Google Scholar